Houssem Benlalam

A <i>ras-</i> Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion

Boris Linard, Stéphane Bezieau, Houssem Benlalam et al. · The Journal of Immunology · 2002 · 86 citations

ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway

Ahmed Hamaï, Franck Meslin, Houssem Benlalam et al. · Cancer Research · 2008 · 80 citations

Ctl Clone, Cancer Immunosurveillance, Differential Susceptibility +13

Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy

Houssem Benlalam, Nathalie Labarrière, Boris Linard et al. · European Journal of Immunology · 2001 · 69 citations · Full text

Immunology, Pathology, Immunophenotyping +18

Hypoxia-Dependent Inhibition of Tumor Cell Susceptibility to CTL-Mediated Lysis Involves NANOG Induction in Target Cells

Meriem Hasmim, Muhammad Zaeem Noman, Jessica Lauriol et al. · The Journal of Immunology · 2011 · 61 citations · Full text

Cell Death, Cancer Biology, Tumor Biology +21

Identification of Five New HLA-B*3501-Restricted Epitopes Derived from Common Melanoma-Associated Antigens, Spontaneously Recognized by Tumor-Infiltrating Lymphocytes

Houssem Benlalam, Boris Linard, Yannik Guilloux et al. · The Journal of Immunology · 2003 · 52 citations · Full text

Histocompatibility, Hla Immunogenetics, Immunology +21